• 看来“无名小卒也”这样的网民在公有制企业里有一大批,那么公有制企业一定会发展的快,搞的好,呵呵。 2019-04-24
  • 广西壮族自治区东兰县“七民一站一阵地工作法”维护群众权益 2019-04-24
  • 孕期压力大影响胎儿大脑发育 2019-04-20
  • 揭秘人民币制作过程 从“白纸”到钞票耗时1个月 2019-04-19
  • 全国高考开展网上评卷 多重保障确保打分公平 2019-04-18
  • 云阳神秘迷宫9月迎客 2019-04-18
  • 儿童家具质量抽检三成不合格 家长选购需注意 2019-04-14
  • 重庆举行龙舟赛迎端午 2019-04-14
  • 菊花茶-热门标签-华商生活 2019-04-10
  • 紫光阁中共中央国家机关工作委员会 2019-04-08
  • 真怒了!台民众镜头前大骂:民进党是什么鬼 2019-04-08
  • 丹霞旅行地中国国家地理网 2019-04-07
  • 乌干达留华学生与中资企业联谊促交流合作 2019-04-07
  • 共产主义既按需分配又按劳分配(原创) 2019-03-31
  • 理论频道——黄河新闻网 2019-03-31
  • About Us

    Shanghai Shyndec Pharmaceutical Co.,Ltd,

    Shanghai Shyndec Pharmaceutical Co.,Ltd, which was established in 1996, is a high-tech enterprise in the pharmaceutical industry which is specialized in manufacturing new drug preparation products and founded by academician of Chinese Academy of Engineering. It was listed on Shanghai stock exchange on June 16, 2004 (stock code: 600420, stock abbreviation:现代制药). In April 2010, it entered China National Pharmaceutical Group Corporation(SINOPHARM).

    In 2016-2017, according to the integration strategy ofSINOPHARM, Shanghai Shyndec Pharmaceutical Co.,Ltd positioned itself as a pharmaceutical industry platform of SINOPHARM, have actively promoted major asset restructuring matters. The main business of the "new Shyndec " wholly-owned or holding subsidiary after the reorganization has achieved nearly 10 billion level of revenue, total profit has exceeded 1 billion yuan, and the number of enterprise members has reached 30, among which 17 are secondary enterprises, 13 are tertiary and four-level enterprises.

    After the reorganization, the "New Shyndec" has integrated into many high-quality industrial product lines and enterprise assets of China National Pharmaceutical Group to create a more centralized resource allocation and a clearer main business market. Focusing on the "anti-infection, cardiovascular and cerebrovascular, anti-tumor, leptin drugs, metabolism and endocrine" five areas then has formed and strengthened the "5 + X" industrial chain system with the modern characteristics and core competitiveness of Chinese medicine. The product structure of the company will be richer, the R&D strength will be further strengthened, and the market position of the enterprise has been improved by leaps and bounds.

    For a year, Shanghai Shyndec Pharmaceutical Co.,Ltd has been guided by "big reorganization, large integration, great amalgamation and fully development". Through the three main paths of " big reorganization of institutional framework, great amalgamation of ideology and culture, great integration of personnel assets" to achieve the development goal of large-scale integration of the group chemical pharmaceutical industry and strive to create a platform of chemical pharmaceutical industry under the guidance of innovation.

    • Stock Code

      600420

    • Stock Abbreviation

      现代制药

    • Company Address:

      Building 1, No. 1320, west Beijing road, Shanghai

    Organizational Structure

  • 看来“无名小卒也”这样的网民在公有制企业里有一大批,那么公有制企业一定会发展的快,搞的好,呵呵。 2019-04-24
  • 广西壮族自治区东兰县“七民一站一阵地工作法”维护群众权益 2019-04-24
  • 孕期压力大影响胎儿大脑发育 2019-04-20
  • 揭秘人民币制作过程 从“白纸”到钞票耗时1个月 2019-04-19
  • 全国高考开展网上评卷 多重保障确保打分公平 2019-04-18
  • 云阳神秘迷宫9月迎客 2019-04-18
  • 儿童家具质量抽检三成不合格 家长选购需注意 2019-04-14
  • 重庆举行龙舟赛迎端午 2019-04-14
  • 菊花茶-热门标签-华商生活 2019-04-10
  • 紫光阁中共中央国家机关工作委员会 2019-04-08
  • 真怒了!台民众镜头前大骂:民进党是什么鬼 2019-04-08
  • 丹霞旅行地中国国家地理网 2019-04-07
  • 乌干达留华学生与中资企业联谊促交流合作 2019-04-07
  • 共产主义既按需分配又按劳分配(原创) 2019-03-31
  • 理论频道——黄河新闻网 2019-03-31
  • 麻将桌 老时时彩360开奖数据 任选9场图标 高频彩51 百度彩票官方电话 金百博五分彩走势图 双色球开 重庆时时彩改为欢乐生肖 足彩17093佬牛解盘分析 a8彩票网址 21點游戏安卓 天津时时彩开奖结果4星 幸运赛车专家推荐号 福彩幸运武林直播 南国七星彩图规 时时彩规律教学